Cargando…
Clindamycin Mono-Therapy of Hidradenitis Suppurativa Patients: A Single-Center Retrospective Study
BACKGROUND: A rifampicin (RF)-clindamycin (CL) combination therapy is recommended as the first-line treatment for moderate to severe hidradenitis suppurativa (HS). Although the long-term use of RF requires caution due to the possibility of developing resistant bacteria, only a few studies have inves...
Autores principales: | An, Ji Hae, Moon, Su Jin, Shin, Jung U, Kim, Dong Hyun, Yoon, Moon Soo, Lee, Hee Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577909/ https://www.ncbi.nlm.nih.gov/pubmed/34858002 http://dx.doi.org/10.5021/ad.2021.33.6.515 |
Ejemplares similares
-
Retrospective Cohort Study on Asian Patients with Hidradenitis Suppurativa: Factors Associated with the Efficacy of Antibiotic Treatment
por: JANG, Yun Kyung, et al.
Publicado: (2022) -
Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa
por: PAHLOW MOSE, Anja, et al.
Publicado: (2022) -
The effect of oral clindamycin and rifampicin combination therapy in patients with hidradenitis suppurativa in Singapore
por: Ochi, Harumi, et al.
Publicado: (2018) -
Innate Immunity Protein Markers Are Significantly Elevated in Hidradenitis Suppurativa Skin Than in Psoriasis Vulgaris
por: Moon, Sujin, et al.
Publicado: (2022) -
Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study
por: Aarts, Pim, et al.
Publicado: (2023)